Intranasal Dexmedetomidine as a Sedative for Pediatric Procedural Sedation
Authors:
- Natalie BehrleNBNatalie Behrle
- Esma BirisciEBEsma Birisci
- Jordan AndersonJAJordan Anderson
- Sara SchroederSSSara Schroeder
- Abdallah DalabihADAbdallah Dalabih
- 1 January 2017
- journal article
- Published by The Pediatric Pharmacy Association in The Journal of Pediatric Pharmacology and Therapeutics
- Vol. 22 (1) , 4-8
Abstract
OBJECTIVE This study seeks to evaluate the efficacy and safety of intranasal (IN) dexmedetomidine as a sedative medication for non-invasive procedural sedation. METHODS Subjects 6 months to 18 years of age undergoing non-invasive elective procedures were included. Dexmedetomidine (3 mcg/kg) was administered IN 40 minutes before the scheduled procedure time. The IN dexmedetomidine cohort was matched and compared to a cohort of 690 subjects who underwent sedation for similar procedures without the use of dexmedetomidine to evaluate for observed events/interventions and procedural times. RESULTS One hundred (92%) of the 109 included subjects were successfully sedated with IN dexmedetomidine. There were no significant differences in the rate of observed events/interventions in comparison to the non-dexmedetomidine cohort. However, the IN dexmedetomidine group had a longer postprocedure sleep time when compared to the non-dexmedetomidine cohort (p < 0.001), which had a significant effect on recovery time (p = 0.024). Also, the dexmedetomidine cohort had longer procedure time and total admit time (p < 0.001 and p = 0.037, respectively). CONCLUSIONS IN dexmedetomidine may be used for non-invasive pediatric procedural sedation. Subjects receiving IN dexmedetomidine had a similar rate of observed events/interventions as the subjects receiving non-dexmedetomidine sedation, with the exception of sleeping time. Also, patients sedated with IN dexmedetomidine had longer time to discharge, procedure time, and total admit time in comparison to other forms of sedation.Keywords
This publication has 17 references indexed in Scilit:
- Comparison of Two Different Intranasal Doses of Dexmedetomidine in Children for Magnetic Resonance Imaging SedationPediatric Drugs, 2015
- Sedation of infants and children outside of the operating roomCurrent Opinion in Anaesthesiology, 2015
- Intranasal dexmedetomidine for sedation in children undergoing transthoracic echocardiography study—a prospective observational studyPediatric Anesthesia, 2015
- A randomized study of intranasal vs. intravenous infusion of dexmedetomidine in gastroscopyInt. Journal of Clinical Pharmacology and Therapeutics, 2014
- A Comparative evaluation of Intrnasal Dexmedetomidine, Midazolam and Ketamine for their sedative and analgesic properties: A Triple Blind Randomized StudyJournal of Clinical Pediatric Dentistry, 2014
- Efficacy of dexmedetomidine compared with midazolam for sedation in adult intensive care patients: a systematic reviewBritish Journal of Anaesthesia, 2013
- Cardiovascular Effects of Dexmedetomidine Sedation in ChildrenAnesthesia & Analgesia, 2012
- A comparison of dexmedetomidine versus midazolam for sedation, pain and hemodynamic control, during colonoscopy under conscious sedationEuropean Journal of Anaesthesiology, 2010
- Sedation challenges in the pediatric ICU: is dexmedetomidine the solution?2009
- High dose dexmedetomidine as the sole sedative for pediatric MRIPediatric Anesthesia, 2008